Reduction of transendothelial migration of mononuclear cells in interferon-β1b-treated multiple sclerosis patients

被引:0
|
作者
Corsini, E [1 ]
Gelati, M [1 ]
Dufour, A [1 ]
Ciusani, E [1 ]
La Mantia, L [1 ]
Massa, G [1 ]
Milanese, C [1 ]
Salmaggi, A [1 ]
机构
[1] Ist Nazl Neurol Carlo Besta, Milan, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:435 / 435
页数:1
相关论文
共 50 条
  • [41] The effects of interferon-β1b on expression of CXCR3 on circulating T cells in multiple sclerosis patients
    Nakajima, H.
    Hosokawa, T.
    Sugino, M.
    Kimura, F.
    Hanafusa, T.
    Ikemoto, T.
    Shimizu, A.
    8TH INTERNATIONAL CONGRESS OF NEUROIMMUNOLOGY, 2006, : 79 - 83
  • [42] Quercetin and interferon-β modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients
    Sternberg, Zohara
    Chadha, Kailash
    Lieberman, Alicia
    Hojnacki, David
    Drake, Allison
    Zamboni, Paolo
    Rocco, Paluch
    Grazioli, Erica
    Weinstock-Guttman, Bianca
    Munschauer, Frederick
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 205 (1-2) : 142 - 147
  • [43] The effects of interferon-β1b on expression of CXCR3 on circulating T cells in multiple sclerosis patients
    Nakajima, H.
    Hosokawa, T.
    Sugino, M.
    Kimura, F.
    Hanafusa, T.
    Ikemoto, T.
    Shimizu, A.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 207 - 207
  • [44] Immmunomodulation by quercetin and interferon-β in multiple sclerosis patients
    Chadha, Kailash
    Sternberg, Zohara
    Lieberman, Alicia
    Drake, Allison
    Weinstock-Guttman, Bianca
    Munschauer, Frederick
    CYTOKINE, 2009, 48 (1-2) : 108 - 108
  • [45] Interferon-β1b treatment modulates cytokines in patients with primary progressive multiple sclerosis
    Dressel, A.
    Kolb, A. K.
    Elitok, E.
    Bitsch, A.
    Bogumil, T.
    Kitze, B.
    Tumani, H.
    Weber, F.
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (06): : 368 - 373
  • [46] Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patients
    Uher, Tomas
    Fellows, Kelly
    Horakova, Dana
    Zivadinov, Robert
    Vaneckova, Manuela
    Sobisek, Lukas
    Tyblova, Michaela
    Seidl, Zdenek
    Krasensky, Jan
    Bergsland, Niels
    Weinstock-Guttman, Bianca
    Havrdova, Eva
    Ramanathan, Murali
    JOURNAL OF LIPID RESEARCH, 2017, 58 (02) : 403 - 411
  • [47] Unveiling a novel immunomodulatory role for interferon-β therapy in multiple sclerosis: The selective reduction of pathogenic memory B cells
    Rizzo, Fabiana
    Giacomini, Elena
    Severa, Martina
    Mechelli, Rosella
    Romano, Silvia
    Ricigliano, Vito Antonio Gerardo
    Salvetti, Marco
    Coccia, Eliana Marina
    CYTOKINE, 2014, 70 (01) : 67 - 67
  • [48] Disability and impact profile in multiple sclerosis patients treated with high-dose interferon-β 1a
    Schluep, M
    Bogousslavsky, J
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S252 - S252
  • [49] Interferon-β1a for the treatment of multiple sclerosis
    Clerico, Marinella
    Contessa, Giulia
    Durelli, Luca
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (04) : 535 - 542
  • [50] Expression profiling identifies genes related to interferon-β-1-α activity in multiple sclerosis in peripheral blood mononuclear cells
    Achiron, A
    Mandel, M
    Snir, Y
    Gurevich, M
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S213 - S213